Hassan Y. Ebrahim

999 citations

41 papers · 789 indexed · h-index 18

Co-authors: Khalid A. El Sayed Mohamed M. Mohyeldin Heba E. Elsayed Abu Bakar Siddique Eman G. Haggag Mohamed R. Akl Nehad M. Ayoub Fatma A. Moharram
Topics: Natural product bioactivities and synthesis (9 papers)Microbial Natural Products and Biosynthesis (6 papers)Cancer, Lipids, and Metabolism (5 papers)
Cited by: Biochemistry Toxicology Biotechnology
Journals: PLoS ONE Cancer Research Scientific Reports
Partner nations: United States Egypt Saudi Arabia

In The Last Decade

Hassan Y. Ebrahim

40 papers receiving 778 citations

Peers

Countries citing papers authored by Hassan Y. Ebrahim

Since Specialization

Citations

This map shows the geographic impact of Hassan Y. Ebrahim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hassan Y. Ebrahim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hassan Y. Ebrahim more than expected).

Fields of papers citing papers by Hassan Y. Ebrahim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hassan Y. Ebrahim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hassan Y. Ebrahim. The network helps show where Hassan Y. Ebrahim may publish in the future.

Co-authorship network of co-authors of Hassan Y. Ebrahim

This figure shows the co-authorship network connecting the top 25 collaborators of Hassan Y. Ebrahim. A scholar is included among the top collaborators of Hassan Y. Ebrahim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hassan Y. Ebrahim. Hassan Y. Ebrahim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Olive Oil Phenolic S-(-)-Oleocanthal Suppresses Colorectal Cancer Progression and Recurrence by Modulating SMYD2-EZH2 and c-MET Activation 2025 ·Nutrients ·(unknown),Heba E. Elsayed,Hassan Y. Ebrahim,Khalid A. El Sayed	4
2	Bioactive metabolites identified from Aspergillus terreus derived from soil 2023 ·AMB Express ·(unknown),Hassan Y. Ebrahim,Mohamed S. Abdel‐Aziz,(unknown),Fatma A. Moharram	3
3	Towards Developing Novel Prostate Cancer Recurrence Suppressors: Acute Toxicity of Pseurotin A, an Orally Active PCSK9 Axis-Targeting Small-Molecule in Swiss Albino Mice 2023 ·Molecules ·(unknown),Hassan Y. Ebrahim,(unknown),(unknown),(unknown),Judy A. King,(unknown),Sharon A. Meyer,Khalid A. El Sayed	3
4	Pseurotin A Validation as a Metastatic Castration-Resistant Prostate Cancer Recurrence-Suppressing Lead via PCSK9-LDLR Axis Modulation 2023 ·Marine Drugs ·(unknown),Abu Bakar Siddique,Hassan Y. Ebrahim,(unknown),(unknown),(unknown),Mourad Zerfaoui,Zakaria Y. Abd Elmageed,Khalid A. El Sayed	5
5	Antimicrobial, antiproliferative activities and molecular docking of metabolites from Alternaria alternata 2023 ·AMB Express ·(unknown),(unknown),Ahmed S. Abdel‐Razek,Ahmed A. Hamed,Hassan Y. Ebrahim,(unknown),Mokhtar Bishr,(unknown),Rabab A. El Dib,Hesham S. M. Soliman	16
6	Melaleuca rugulosa (Link) Craven Tannins: Appraisal of anti-inflammatory, radical scavenging activities, and molecular modeling studies 2022 ·Journal of Ethnopharmacology ·Hassan Y. Ebrahim,(unknown),(unknown),(unknown),Heba E. Elsayed,Fatma A. Moharram	12
7	Anti-prostate cancer metabolites from the soil-derived Aspergillus neoniveus 2022 ·Frontiers in Pharmacology ·(unknown),Hassan Y. Ebrahim,Heba E. Elsayed,Mohamed S. Abdel‐Aziz,Benson M. Kariuki,Fatma A. Moharram	5
8	Polyphenolic profile and ethno pharmacological activities of Callistemon subulatus (Cheel) Craven leaves cultivated in Egypt 2021 ·Journal of Ethnopharmacology ·(unknown),Heba E. Elsayed,(unknown),Ahmed A. Hussein,Hassan Y. Ebrahim,Fatma A. Moharram	14
9	Synthesis, anticancer evaluation and molecular docking studies of new heterocycles linked to sulfonamide moiety as novel human topoisomerase types I and II poisons 2020 ·Bioorganic Chemistry ·Ahmed H. Halawa,Walid E. Elgammal,(unknown),(unknown),(unknown),Hassan Y. Ebrahim,Ahmed B. M. Mehany,Ahmed M. El‐Agrody	36
10	Rational Design and Synthesis of Diverse Pyrimidine Molecules Bearing Sulfonamide Moiety as Novel ERK Inhibitors 2019 ·International Journal of Molecular Sciences ·Ahmed H. Halawa,Areej A. Eskandrani,Walid E. Elgammal,(unknown),(unknown),Hassan Y. Ebrahim,Ahmed B. M. Mehany,Ahmed M. El‐Agrody,Rawda M. Okasha	18
11	Prodigiosins from a marine sponge-associated actinomycete attenuate HCl/ethanol-induced gastric lesion via antioxidant and anti-inflammatory mechanisms 2019 ·PLoS ONE ·Mohamed S. Abdelfattah,Mohammed I. Y. Elmallah,Hassan Y. Ebrahim,Rafa Almeer,(unknown),Ahmed E. Abdel Moneim	52
12	Novel liquid-liquid extraction and self-emulsion methods for simplified isolation of extra-virgin olive oil phenolics with emphasis on (-)-oleocanthal and its oral anti-breast cancer activity 2019 ·PLoS ONE ·Abu Bakar Siddique,Hassan Y. Ebrahim,Mohamed M. Mohyeldin,(unknown),Yazan S. Batarseh,(unknown),(unknown),Sami Nazzal,Amal Kaddoumi,Khalid A. El Sayed	41
13	(−)-Oleocanthal Combined with Lapatinib Treatment Synergized against HER-2 Positive Breast Cancer In Vitro and In Vivo 2019 ·Nutrients ·Abu Bakar Siddique,Hassan Y. Ebrahim,Mohamed R. Akl,Nehad M. Ayoub,(unknown),Mohamed M. Mohyeldin,(unknown),Wael Hananeh,Yu Liu,Sharon A. Meyer,Khalid A. El Sayed	26
14	Rationally designed hecogenin thiosemicarbazone analogs as novel MEK inhibitors for the control of breast malignancies 2017 ·Bioorganic & Medicinal Chemistry ·Heba E. Elsayed,Hassan Y. Ebrahim,Eman G. Haggag,(unknown),Khalid A. El Sayed	22
15	The olive oil phenolic (-)-oleocanthal modulates estrogen receptor expression in luminal breast cancer in vitro and in vivo and synergizes with tamoxifen treatment 2017 ·European Journal of Pharmacology ·Nehad M. Ayoub,Abu Bakar Siddique,Hassan Y. Ebrahim,Mohamed M. Mohyeldin,Khalid A. El Sayed	59
16	The oleocanthal-based homovanillyl sinapate as a novel c-Met inhibitor 2016 ·Oncotarget ·Mohamed M. Mohyeldin,Mohamed R. Akl,Hassan Y. Ebrahim,Ana Maria Dragoi,Samantha S. Dykes,James A. Cardelli,Khalid A. El Sayed	17
17	The indole alkaloid meleagrin, from the olive tree endophytic fungus Penicillium chrysogenum, as a novel lead for the control of c-Met-dependent breast cancer proliferation, migration and invasion 2015 ·Bioorganic & Medicinal Chemistry ·(unknown),Mohamed M. Mohyeldin,Hassan Y. Ebrahim,Heba E. Elsayed,Wael E. Houssen,Eman G. Haggag,(unknown),Khalid A. El Sayed	47
18	PEGylated γ-tocotrienol isomer of vitamin E: Synthesis, characterization, in vitro cytotoxicity, and oral bioavailability 2015 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown),Fathy A. Behery,(unknown),Saeed Alqahtani,Hassan Y. Ebrahim,Khalid A. El Sayed,Amal Kaddoumi,Paul W. Sylvester,Jennifer L. Carroll,James A. Cardelli,Sami Nazzal	26
19	Araguspongine C Induces Autophagic Death in Breast Cancer Cells through Suppression of c-Met and HER2 Receptor Tyrosine Kinase Signaling 2015 ·Marine Drugs ·Mohamed A. Akl,Nehad M. Ayoub,Hassan Y. Ebrahim,Mohamed M. Mohyeldin,Khaled Y. Orabi,Ahmed I. Foudah,Khalid A. El Sayed	32
20	Inflammatory metastatic breast cancer with gallbladder metastasis: an incidental finding 2015 ·The Journal of Community and Supportive Oncology ·Hassan Y. Ebrahim,David L. Graham,David C. Rice,(unknown),(unknown),W. Shipley,(unknown)	1

About Hassan Y. Ebrahim

Hassan Y. Ebrahim is a scholar working on Applied Microbiology and Biotechnology, Biotechnology and Biochemistry, having authored 41 papers that have together received 789 indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (9 papers), Microbial Natural Products and Biosynthesis (6 papers) and Cancer, Lipids, and Metabolism (5 papers). The work is most often cited by research in Biochemistry (126 citations), Toxicology (45 citations) and Biotechnology (97 citations). Hassan Y. Ebrahim has collaborated with scholars based in United States, Egypt and Saudi Arabia. Frequent co-authors include Khalid A. El Sayed, Mohamed M. Mohyeldin, Heba E. Elsayed, Abu Bakar Siddique, Eman G. Haggag, Mohamed R. Akl, Nehad M. Ayoub, Fatma A. Moharram, Ahmed I. Foudah and Mohamed A. Akl. Their work appears in journals such as PLoS ONE, Cancer Research and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact